Amneal Pharmaceuticals, Inc. Class A Common Stock
Veridion Score
Composite trend over time
Why is AMRX moving today?
Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE. It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment, which derives maximum revenue, focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
Warehouse intelligence for AMRX.
AMRX insider activity
Amneal Pharmaceuticals, Inc. Class A Common Stock
No multi-insider buying cluster in the last 90 days
Net selling: -$35.2M across loaded Form 4 rows.
Loaded official disclosures do not show all three sources aligned on this ticker.
| Filing date | Trade date | Insider | Title | Type | Price | Qty | Owned | Value | Receipt |
|---|---|---|---|---|---|---|---|---|---|
| 2026-05-12 | 2026-05-11 | Autor Deborah M. | Insider | sell | $12.94 | 34,819 | 93,660 | $451K | SEC Form 4 |
| 2026-03-05 | 2026-03-04 | Patel Chintu | Insider | sell | $13.30 | 28,983 | 1,388,521 | $385K | SEC Form 4 |
| 2026-03-05 | 2026-03-04 | Patel Chirag K. | Insider | sell | $13.30 | 37,825 | 1,393,470 | $503K | SEC Form 4 |
| 2026-03-05 | 2026-03-04 | Daly Jason B. | Insider | sell | $13.30 | 15,580 | 251,784 | $207K | SEC Form 4 |
| 2026-03-05 | 2026-03-04 | Shah Nikita | Insider | sell | $13.30 | 17,976 | 399,793 | $239K | SEC Form 4 |
Showing 5 recent rows. Sovereign unlocks 38 additional rows, full sorting, and the named-filer history.
Upgrade to Sovereign · $25/moAMRX contract awards, year to date.
Public federal awards linked to this ticker.
AMRX lobbying filings, year to date.
Registered lobbying filings matched to Amneal Pharmaceuticals, Inc. Class A Common Stock.